Valproate Sodium Injection Shortage: Current Availability and Manufacturer Updates
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA continues to monitor a shortage of Valproate Sodium Injection, a neurology medication. While supply is currently reported as available, inventory checks are recommended.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Valproate Sodium.
What's in Shortage
Valproate Sodium Injection (Generic: Valproate Sodium Injection; Brand: VALPROATE SODIUM) is currently listed on the FDA drug shortage database. This medication is an injection dosage form primarily used within the Neurology therapeutic category. The shortage was first posted on December 30, 2020, and the most recent update was provided on February 5, 2026.
Which Manufacturers Are Affected
Currently, the following manufacturer is listed in the database regarding this shortage:
- Fresenius Kabi USA, LLC
- Status: Available
- Presentation: Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05)
- Notes: The manufacturer advises checking with wholesalers for current inventory.
- Contact Info: 888-386-1300
Why There's a Shortage
No specific reason for the shortage of Valproate Sodium Injection was provided in the current FDA report.
What Patients Should Do
If you or a loved one relies on Valproate Sodium Injection, consider the following steps:
- Consult Your Healthcare Provider: Discuss your treatment plan and any concerns regarding medication availability. Do not make changes to your medication regimen without professional medical advice.
- Speak with Your Pharmacist: Pharmacists often have the most up-to-date information on local stock and can check with multiple wholesalers to locate available supply.
- Contact the Manufacturer: You may reach out to Fresenius Kabi USA, LLC directly at 888-386-1300 for specific information regarding their current supply levels.
Disclaimer: This article is for informational purposes only. Patients should always consult with their healthcare provider or pharmacist regarding medical treatments and alternatives.
Source
Information provided by the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.